Inhouse product
Indications
Montene is indicated for:
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Pharmacology
Montelukast is a selective and orally active
leukotriene receptor antagonist that inhibits the cysteinyl leukotriene
receptor (CysLT1). The cysteinyl leukotrienes (LTC4, LTD4, LTE4) are products of
arachidonic acid metabolism and are released from various cells, including mast
cells and eosinophils. Cysteinyl leukotrienes and leukotriene receptor
occupation have been correlated with the pathophysiology of asthma &
allergic rhinitis, including airway edema, smooth muscle contraction, and
altered cellular activity associated with the inflammatory process, which
contribute to the signs and symptoms of asthma.
Dosage & Administration
Adults and adolescents with asthma or seasonal
allergic rhinitis:
Pediatric patients
with asthma or seasonal allergic rhinitis:
Use in the pediatric
patient: The safety and
efficacy of Montelukast have been established in adequate and well-controlled
studies in pediatric patients with asthma 6 months to 14 years of age. Safety
and efficacy profiles in this age group are similar to those seen in adults.
Hepatic Insufficiency: No dosage adjustment is required in patients
with mild-to-moderate hepatic insufficiency.
Renal Insufficiency: No dosage adjustment is recommended in
patients with renal insufficiency.
Elderly use: The pharmacokinetic profile and the oral
bioavailability of a single 10-mg oral dose of montelukast are similar in
elderly and younger adults. The plasma half-life of montelukast is slightly
longer in the elderly. No dosage adjustment in the elderly is required.
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Interaction
Montene has been administered with other
therapies routinely used in the prophylaxis and chronic treatment of asthma
with no apparent increase in adverse reactions. In drug interaction studies,
the recommended clinical dose of Montene did not have clinically important
effects on the pharmacokinetics of the following drugs: theophylline,
prednisone, prednisolone, oral contraceptives (norethindrone 1mg/ethinyl
estradiol 35mcg), terfenadine, digoxin, and warfarin. Although additional
specific interaction studies were not performed, Montene was used concomitantly
with a wide range of commonly prescribed drugs in clinical studies without
evidence of clinical adverse interactions. These medications included thyroid
hormones, sedative hypnotics, non-steroidal anti-inflammatory agents,
benzodiazepines and decongestants. Phenobarbital, which induces hepatic
metabolism, decreased the AUC of Montene approximately 40% following a single
10mg dose of Montene. No dosage adjustment for Montene is recommended. It is
reasonable to employ appropriate clinical monitoring when potent cytochrome
P450 enzyme inducers, such as phenobarbital or rifampin, are co-administered
with Montene.
Contraindications
Montelukast is contraindicated in patients who
are hypersensitive to any component of this product.
Side Effects
Common: Diarrhoea, fever, gastrointestinal discomfort, headache,
nausea, vomiting, skin reactions, upper respiratory tract infection.
Uncommon: Akathisia, anxiety, arthralgia, asthenia,
abnormal behavior, depression, dizziness, drowsiness, dry mouth, haemorrhage,
irritability, malaise, muscle complaints, oedema, seizure, abnormal sensation,
sleep disorders.
Rare: Angioedema, concentration impaired,
disorientation, eosinophilic granulomatosis with polyangiitis, erythema
nodosum, hallucination, hepatic disorders, memory loss, palpitations, pulmonary
eosinophilia, suicidal tendencies, tremor.
Pregnancy & Lactation
Montelukast crosses the placenta following
oral dosing in rats and rabbits. There are, however, no adequate and
well-controlled studies in pregnant women. Because animal reproduction studies
are not always predictive of human response, Montelukast should be used during
pregnancy only if clearly needed. Because many drugs are excreted in human
milk, caution should be exercised when Montelukast is given to a nursing
mother.
Precautions & Warnings
Montene is not indicated for use in the
reversal of bronchospasm in acute asthma attacks, including status asthmaticus.
Patients should be advised to have appropriate rescue medication available.
Therapy with Montene can be continued during acute exacerbations of asthma.
While the dose of inhaled corticosteroid may be reduced gradually under medical
supervision, Montene should not be abruptly substituted for inhaled or oral
corticosteroids. Montene should not be used as monotherapy for the treatment
and management of exercise induced bronchospasm. Patients with known aspirin
sensitivity should continue avoidance of aspirin or non-steroidal
anti-inflammatory agents while taking Montene. Although Montene is effective in
improving airway function in asthmatics with documented aspirin sensitivity, it
has not been shown to truncate bronchoconstrictor response to aspirin and other
non-steroidal anti-inflammatory drugs in aspirin-sensitive asthmatic patients.
Overdose Effects
There were no adverse experiences in the
majority of overdosage reports. The most frequently occurring adverse
experiences were consistent with the safety profile of Montene and included
abdominal pain, somnolence, thirst, headache, vomiting and psychomotor
hyperactivity. In the event of overdose, it is reasonable to employ the usual
supportive measures; e.g., remove unabsorbed material from the gastrointestinal
tract, employ clinical monitoring, and institute supportive therapy, if
required.
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Store in cool & dry place below 30°C,
protect from light & moisture. Keep out of reach of children.
Chemical Structure
|
Molecular Formula : |
C35H36ClNO3S |
|
Chemical Structure : |
Common Questions about Montene 4 mg Tablet
What is Montene 4 mg DT?
Montene 4 mg DT is a selective and orally
active leukotriene receptor antagonist.
What is Montene 4 mg DT used for?
Montene 4 mg DT is commonly used to treat
asthma or allergic rhinitis. It helps keep airways open and easy breathing by
blocking leukotrienes.
How soon can the effect of Montene 4 mg DT be
observed?
The effect of Montene 4 mg DT can be observed
after 1-3 hours of administration. Montene 4 mg DT is not a fast-acting rescue
medicine for asthma attacks and needs to be taken daily to work properly.
How long does the effect of Montene 4 mg DT
last?
The effect of Montene 4 mg DT lasts for an
average duration of 24 hours.
Should I use Montene 4 mg DT empty stomach?
Montene 4 mg DT may be taken with or without
food as prescribed by your doctor.
What if I miss a dose of Montene 4 mg DT?
If you miss a dose, you may take it as soon as
possible. But if it is almost time for your next dose, just skip that dose. Do
not double up on doses.
Are there any pregnancy warnings for Montene 4
mg DT?
Use of Montene 4 mg DT in pregnant women
should be avoided unless clearly needed.
General Instructions
* রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'
Login Or Registerto submit your questions to seller
No none asked to seller yet